These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21636704)

  • 1. Neurocognitive function: an emerging surrogate endpoint for neuro-oncology trials.
    Weller M
    Neuro Oncol; 2011 Jun; 13(6):565. PubMed ID: 21636704
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.
    Wefel JS; Cloughesy T; Zazzali JL; Zheng M; Prados M; Wen PY; Mikkelsen T; Schiff D; Abrey LE; Yung WK; Paleologos N; Nicholas MK; Jensen R; Vredenburgh J; Das A; Friedman HS
    Neuro Oncol; 2011 Jun; 13(6):660-8. PubMed ID: 21558074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive impairments in brain tumor patients.
    Kehayov II; Kitov BD; Zhelyazkov CB; Raykov SD; Davarski AN
    Folia Med (Plovdiv); 2012; 54(4):14-21. PubMed ID: 23441465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive functions in brain tumor patients.
    Correa DD
    Hematol Oncol Clin North Am; 2006 Dec; 20(6):1363-76. PubMed ID: 17113468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cognitive functions and quality of life.
    Taphoorn MJ; Klein M
    Handb Clin Neurol; 2012; 104():173-83. PubMed ID: 22230444
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neurocognitive deficits in patients with malignant brain tumors].
    Dinkel A; Geinitz H; Ringel F; Herschbach P
    Psychother Psychosom Med Psychol; 2012; 62(3-4):89-94. PubMed ID: 22473426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
    Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for preservation of memory function in patients with brain metastases.
    Dye NB; Gondi V; Mehta MP
    Chin Clin Oncol; 2015 Jun; 4(2):24. PubMed ID: 26112810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): The Canadian registry experience.
    Lafay-Cousin L; Fay-McClymont T; Johnston D; Fryer C; Scheinemann K; Fleming A; Hukin J; Janzen L; Guger S; Strother D; Mabbott D; Huang A; Bouffet E
    Pediatr Blood Cancer; 2015 Jul; 62(7):1265-9. PubMed ID: 25787232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive and quality of life measures in patients with metastatic brain disease.
    Witgert ME; Meyers CA
    Neurosurg Clin N Am; 2011 Jan; 22(1):79-85, vii. PubMed ID: 21109152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre- and postoperative neurocognitive deficits in brain tumor patients assessed by a computer based screening test.
    Hoffermann M; Bruckmann L; Mahdy Ali K; Zaar K; Avian A; von Campe G
    J Clin Neurosci; 2017 Feb; 36():31-36. PubMed ID: 27836394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe Glioma.
    Noll KR; Weinberg JS; Ziu M; Benveniste RJ; Suki D; Wefel JS
    Neurosurgery; 2015 Nov; 77(5):777-85. PubMed ID: 26317672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of cognitive deficits and mood disturbance.
    Meyers CA
    Handb Clin Neurol; 2012; 104():363-9. PubMed ID: 22230454
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of medical and neurosurgical events with neuropsychological status in children at diagnosis of astrocytoma: utilization of a neurological severity score.
    Ater JL; Moore BD; Francis DJ; Castillo R; Slopis J; Copeland DR
    J Child Neurol; 1996 Nov; 11(6):462-9. PubMed ID: 9120225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression.
    Meyers CA; Hess KR
    Neuro Oncol; 2003 Apr; 5(2):89-95. PubMed ID: 12672280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates from the 2013 Society for Neuro-Oncology annual and World Federation for Neuro-Oncology quadrennial meeting.
    Lukas RV; Amidei C
    Tumori; 2014; 100(3):358-62. PubMed ID: 25076251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating biological insights into clinical endpoints in neuro-oncology.
    Bredel M
    Lancet Oncol; 2009 Oct; 10(10):928-9. PubMed ID: 19628430
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurocognitive status in patients with newly-diagnosed brain tumors in good neurological condition: The impact of tumor type, volume, and location.
    Hendrix P; Hans E; Griessenauer CJ; Simgen A; Oertel J; Karbach J
    Clin Neurol Neurosurg; 2017 May; 156():55-62. PubMed ID: 28334687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a Cognition Endpoint for Traumatic Brain Injury Clinical Trials.
    Silverberg ND; Crane PK; Dams-O'Connor K; Holdnack J; Ivins BJ; Lange RT; Manley GT; McCrea M; Iverson GL
    J Neurotrauma; 2017 Jan; 34(2):363-371. PubMed ID: 27188248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment neuropsychological deficits in children with brain tumors.
    Iuvone L; Peruzzi L; Colosimo C; Tamburrini G; Caldarelli M; Di Rocco C; Battaglia D; Guzzetta F; Misciagna S; Di Giannatale A; Ruggiero A; Riccardi R
    Neuro Oncol; 2011 May; 13(5):517-24. PubMed ID: 21372071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.